Therapeutic Effect of Pirarubicin-Based Chemotherapy for Osteosarcoma Patients with Lung MetastasisHUI ZHAO; YANG YAO; ZHIYU WANG et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 2, pp 119-124, issn 1120-009X, 6 p.Article

In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastasesDARUWALLA, Jurstine; NIKFARJAM, Mehrdad; GREISH, Khaled et al.Cancer science. 2010, Vol 101, Num 8, pp 1866-1874, issn 1347-9032, 9 p.Article

SERR study of the interaction of anthracyclines with mono- and bilayers of charged phospholipidsHEYWANG, C; SAINT-PIERRE-CHAZALET, M; MASSON, M et al.Langmuir. 1997, Vol 13, Num 21, pp 5634-5643, issn 0743-7463Article

Possibility of contribution of nucleoside transport systems to pirarubicin uptake by HL60 cells but not mononuclear cellsNAGASAWA, K; OHNISHI, N; YOKOYAMA, T et al.Japanese journal of cancer research. 1998, Vol 89, Num 6, pp 673-680, issn 0910-5050Article

Liquid chromatographic analysis of arabinosylcytosin and 1-β-D-arabinofuranosyluracil in treatment with cyclophosphamide and pirarubicinZHANG, H; FANG, Y; LI, Y et al.Chromatographia (Wiesbaden). 2006, Vol 63, Num 3-4, pp 203-207, issn 0009-5893, 5 p.Article

A sensitive and reproducible HPLC assay for doxorubicin and pirarubicinJACQUET, J. M; GALTIER, M; BRESSOLLE, F et al.Journal of pharmaceutical and biomedical analysis. 1992, Vol 10, Num 5, pp 343-348, issn 0731-7085Article

Evaluation of the effect of SMA-pirarubicin micelles on colorectal cancer liver metastases and of hyperbaric oxygen in CBA miceDARUWALLA, Jurstine; GREISH, Khaled; NIKFARJAM, Mehrdad et al.Journal of drug targeting. 2007, Vol 15, Num 7-8, pp 487-495, issn 1061-186X, 9 p.Article

Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude miceFAVOULET, Patrick; BENOIT, Laurent; OSMAK, Liliana et al.World journal of surgery. 2004, Vol 28, Num 5, pp 451-456, issn 0364-2313, 6 p.Article

Uptake of the anthracycline pirarubicin into mouse M5076 ovarian sarcoma cells via a sodium-dependent nucleoside transport systemNAGAI, Katsuhito; NAGASAWA, Kazuki; FUJIMOTO, Sadaki et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 3, pp 222-230, issn 0344-5704, 9 p.Article

Réponse majeure d'un volumineux carcinome hépatocellulaire à une chimioembolisation par pirarubicine, amiodarone et Lipiodol® = Sustained clinical response of large hepatocellular carcinoma after chemoembolization with pirarubicin, amiodarone and Lipiodol®CERCUEIL, Jean-Pierre; FERRANT, Emmanuelle; ISAMBERT, Nicolas et al.Gastroentérologie clinique et biologique. 2004, Vol 28, Num 12, pp 1281-1283, issn 0399-8320, 3 p.Article

Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublinesMEESUNGNOEN, Jintana; JAY-GERIN, Jean-Paul; MANKHETKORN, Samlee et al.Canadian journal of physiology and pharmacology. 2002, Vol 80, Num 11, pp 1054-1063, issn 0008-4212, 10 p.Article

Incorporation of exogenous molecules inside mono- and bilayers of phospholipids : Influence of the mode of preparation revealed by SERRS and surface pressure studiesHEYWANG, C; SAINT-PIERRE CHAZALET, M; MASSON, M et al.Langmuir. 1996, Vol 12, Num 26, pp 6459-6467, issn 0743-7463Article

Les nouvelles drogues en chimiothérapie anticancéreuse = New drugs for antimitotic chemotherapyLEVEQUE, D; JEHL, F.Journal de médecine de Strasbourg. 1994, Vol 25, Num 3-4, pp 130-136, issn 0021-7905Article

Distribution of pirarubicin in human bloodNAGASAWA, K; KITADA, N; TSUJI, C et al.Chemical and pharmaceutical bulletin. 1992, Vol 40, Num 10, pp 2866-2869, issn 0009-2363Article

Activity of pirarubicin (4'-0-tetrahydropyranyladriamycin) in malignant mesotheliomaSRIDHAR, K. S; HUSSEIN, A. M; FEUN, L. G et al.Cancer. 1989, Vol 63, Num 6, pp 1084-1091, issn 0008-543XArticle

Rational use of biological response modifiers in cancer and related diseases, Pavia, 11-22 September 1988REIZENSTEIN, P.Medical oncology and tumor pharmacotherapy. 1989, Vol 6, Num 1, pp 1-113, issn 0736-0118Conference Proceedings

Phase I study of pirarubicinMILLER, A. A; SCHEULEN, M. E; KLEEBERG, U. R et al.Journal of cancer research and clinical oncology. 1988, Vol 114, Num 1, pp 91-94, issn 0171-5216Article

Accumulation of degradation products of doxorubicin and pirarubicin formed in cell culture medium within sensitivie and resistant cellsFIALLO, M; LAIGLE, A; BORREL, M.-N et al.Biochemical pharmacology. 1993, Vol 45, Num 3, pp 659-665, issn 0006-2952Article

Small Cell Osteosarcoma Successfully Treated by High-dose Ifosfamide and Methotrexate, Combined with Carboplatin and PirarubicinFUTANI, Hiroyuki; FUKUNAGA, Satoru; TSUKAMOTO, Yoshitane et al.Anticancer research. 2012, Vol 32, Num 3, pp 965-971, issn 0250-7005, 7 p.Article

Styrene Maleic Acid-Pirarubicin Disrupts Tumor Microcirculation and Enhances the Permeability of Colorectal Liver MetastasesDARUWALLA, Jurstine; GREISH, Khaled; MALCONTENTI-WILSON, Cathy et al.Journal of vascular research. 2009, Vol 46, Num 3, pp 218-228, issn 1018-1172, 11 p.Article

Structurally different anthracyclines provoke different effects on cell cycle and tumor B cell differentiationTEILLAUD, J. L; GRUEL, N; MONCUIT, J et al.Biomedicine & pharmacotherapy. 1998, Vol 52, Num 6, pp 282-290, issn 0753-3322Article

Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70 years with diffuse large B cell lymphomaHARA, Takeshi; TSURUMI, Hisashi; SAWADA, Michio et al.Journal of cancer research and clinical oncology. 2010, Vol 136, Num 1, pp 65-70, issn 0171-5216, 6 p.Article

Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-hodgkin's lymphoma: A comparison of doxorubicin and pirarubicin: A randomized phase II studyTSURUMI, Hisashi; YAMADA, Toshiki; OYAMA, Masami et al.Journal of cancer research and clinical oncology. 2004, Vol 130, Num 2, pp 107-113, issn 0171-5216, 7 p.Article

Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group TrialITO, Akihiro; SHINTAKU, Ichiro; NAMIKI, Shunichi et al.Journal of clinical oncology. 2013, Vol 31, Num 11, pp 1422-1427, issn 0732-183X, 6 p.Article

Postoperative adjuvant chemotherapy with cisplatin, etoposide, and pirarubicin for endometrial carcinoma patients with lymph node metastasis : A pilot studyUMESAKI, N; TANAKA, T; MIYAMA, M et al.Oncology reports. 2000, Vol 7, Num 5, pp 1083-1086, issn 1021-335XArticle